191 related articles for article (PubMed ID: 24969544)
1. Vitamin C enhances anticancer activity in methotrexate‑treated Hep3B hepatocellular carcinoma cells.
Yiang GT; Chou PL; Hung YT; Chen JN; Chang WJ; Yu YL; Wei CW
Oncol Rep; 2014 Sep; 32(3):1057-63. PubMed ID: 24969544
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with vitamin C and methotrexate inhibits triple-negative breast cancer cell growth by increasing H2O2 accumulation and activating caspase-3 and p38 pathways.
Wu CW; Liu HC; Yu YL; Hung YT; Wei CW; Yiang GT
Oncol Rep; 2017 Apr; 37(4):2177-2184. PubMed ID: 28259996
[TBL] [Abstract][Full Text] [Related]
3. Naringin alleviates methotrexate-induced liver injury in male albino rats and enhances its antitumor efficacy in HepG2 cells.
Elsawy H; Algefare AI; Alfwuaires M; Khalil M; Elmenshawy OM; Sedky A; Abdel-Moneim AM
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458964
[TBL] [Abstract][Full Text] [Related]
4. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats.
Saleem S; Kazmi I; Ahmad A; Abuzinadah MF; Samkari A; Alkrathy HM; Khan R
Nutr Cancer; 2020; 72(1):170-181. PubMed ID: 31088230
[No Abstract] [Full Text] [Related]
5. Methotrexate and 5-aminoimidazole-4-carboxamide riboside exert synergistic anticancer action against human breast cancer and hepatocellular carcinoma.
Cheng XL; Zhou TY; Li B; Li MY; Li L; Li ZQ; Lu W
Acta Pharmacol Sin; 2013 Jul; 34(7):951-9. PubMed ID: 23603981
[TBL] [Abstract][Full Text] [Related]
6. Oxyphenbutazone promotes cytotoxicity in rats and Hep3B cellsvia suppression of PGE
Saleem S; Khan R; Afzal M; Kazmi I
Mol Cell Biochem; 2018 Jul; 444(1-2):187-196. PubMed ID: 29204817
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effects of methotrexate in combination with α‑tocopherol and α‑tocopherol succinate on triple‑negative breast cancer.
Wei CW; Yu YL; Chen YH; Hung YT; Yiang GT
Oncol Rep; 2019 Mar; 41(3):2060-2066. PubMed ID: 30628707
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone enhances 5-fluorouracil-induced cell growth inhibition in hepatocellular carcinoma cell line Hep3B.
Cao LQ; Shao ZL; Peng HP; Xiao JB; Xia T
Chin J Cancer; 2010 Aug; 29(8):741-6. PubMed ID: 20663321
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity.
Rouleau L; Antony AN; Bisetto S; Newberg A; Doria C; Levine M; Monti DA; Hoek JB
Free Radic Biol Med; 2016 Jun; 95():308-322. PubMed ID: 27036367
[TBL] [Abstract][Full Text] [Related]
10. Cold Atmospheric Pressure Plasma-Activated Medium Induces Selective Cell Death in Human Hepatocellular Carcinoma Cells Independently of Singlet Oxygen, Hydrogen Peroxide, Nitric Oxide and Nitrite/Nitrate.
Li Y; Tang T; Lee H; Song K
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074016
[TBL] [Abstract][Full Text] [Related]
11. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
[TBL] [Abstract][Full Text] [Related]
12. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma.
Guo L; Li H; Fan T; Ma Y; Wang L
Life Sci; 2021 Aug; 279():119359. PubMed ID: 33753114
[TBL] [Abstract][Full Text] [Related]
13. Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines.
Herman S; Zurgil N; Deutsch M
Inflamm Res; 2005 Jul; 54(7):273-80. PubMed ID: 16134056
[TBL] [Abstract][Full Text] [Related]
14. Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α.
Kim SM; Han JM; Le TT; Sohng JK; Jung HJ
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516967
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.
Lee JY; Jung KH; Morgan MJ; Kang YR; Lee HS; Koo GB; Hong SS; Kwon SW; Kim YS
Mol Cancer Ther; 2013 Mar; 12(3):274-85. PubMed ID: 23053497
[TBL] [Abstract][Full Text] [Related]
16. Morin enhances auranofin anticancer activity by up-regulation of DR4 and DR5 and modulation of Bcl-2 through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells.
Hwang-Bo H; Lee WS; Nagappan A; Kim HJ; Panchanathan R; Park C; Chang SH; Kim ND; Leem SH; Chang YC; Kwon TK; Cheong JH; Kim GS; Jung JM; Shin SC; Hong SC; Choi YH
Phytother Res; 2019 May; 33(5):1384-1393. PubMed ID: 30887612
[TBL] [Abstract][Full Text] [Related]
17. Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma.
Wang Z; Gu C; Wang X; Lang Y; Wu Y; Wu X; Zhu X; Wang K; Yang H
Med Oncol; 2019 Oct; 36(12):97. PubMed ID: 31664534
[TBL] [Abstract][Full Text] [Related]
18. Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein.
Ikemura K; Hiramatsu SI; Shinogi Y; Nakatani Y; Tawara I; Iwamoto T; Katayama N; Okuda M
Sci Rep; 2019 Dec; 9(1):20359. PubMed ID: 31889141
[TBL] [Abstract][Full Text] [Related]
19. Metabolome Analysis Reveals Excessive Glycolysis via PI3K/AKT/mTOR and RAS/MAPK Signaling in Methotrexate-Resistant Primary CNS Lymphoma-Derived Cells.
Takashima Y; Hayano A; Yamanaka R
Clin Cancer Res; 2020 Jun; 26(11):2754-2766. PubMed ID: 32108030
[TBL] [Abstract][Full Text] [Related]
20. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]